BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27500510)

  • 1. Differences in Uptake of 18F-FDG and 11C-Choline in a Case of Acute Myeloid Leukemia.
    Qin C; Wu Z; Li J; Sun X; Lan X
    Clin Nucl Med; 2016 Oct; 41(10):799-801. PubMed ID: 27500510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain 18 F-FET in a Case of Acute Myeloid Leukemia.
    Castello A; Crosta G; Pacella S; Florimonte L; Castellani M
    Clin Nucl Med; 2023 Nov; 48(11):e542-e543. PubMed ID: 37703492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of 18F-FDG PET-CT for Detection of Active Disease in Acute Myeloid Leukemia.
    Elojeimy S; Luana Stanescu A; Parisi MT
    Clin Nucl Med; 2016 Mar; 41(3):e137-40. PubMed ID: 26402136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
    Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
    World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET/CT Findings of Intracardiac Myeloid Sarcoma.
    Niu N; Cui R; Li F
    Clin Nucl Med; 2016 Mar; 41(3):235-6. PubMed ID: 26505855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
    Tian M; Zhang H; Oriuchi N; Higuchi T; Endo K
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1064-72. PubMed ID: 15014903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Philadelphia chromosome-positive acute myeloid leukemia with masses and osteolytic lesions: finding of 18F-FDG PET/CT.
    Su Z; Wu F; Hu W; Liu X; Wu S; Feng X; Cui Z; Yang J; Wang Z; Guan H; Zhao H; Wang W; Zhao C; Peng J
    Front Med; 2017 Sep; 11(3):440-444. PubMed ID: 28550639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Marrow Involvement in Unknown Acute Myeloid Leukemia Detected by 18F-FDG PET/MRI.
    Paone G; Stüssi G; Pons M; Giovanella L; Ceriani L
    Clin Nucl Med; 2015 Oct; 40(10):e486-7. PubMed ID: 26204209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of brain tumors with radiolabeled choline PET.
    Calabria FF; Barbarisi M; Gangemi V; Grillea G; Cascini GL
    Neurosurg Rev; 2018 Jan; 41(1):67-76. PubMed ID: 27230829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misdiagnoses of 11C-choline combined with 18F-FDG PET imaging in brain tumours.
    Huang Z; Zuo C; Guan Y; Zhang Z; Liu P; Xue F; Lin X
    Nucl Med Commun; 2008 Apr; 29(4):354-8. PubMed ID: 18317300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
    Pieterman RM; Que TH; Elsinga PH; Pruim J; van Putten JW; Willemsen AT; Vaalburg W; Groen HJ
    J Nucl Med; 2002 Feb; 43(2):167-72. PubMed ID: 11850480
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kiyoki Y; Matsuoka R; Kaneta T; Nishikii H
    Int J Hematol; 2020 Oct; 112(4):433-434. PubMed ID: 32865707
    [No Abstract]   [Full Text] [Related]  

  • 13. An atypical relapse of acute myeloid leukemia diagnosed by 18F-FDG PET/CT.
    Schollaert P; Loosen C; André M; Chatelain B; Krug BM
    Clin Nucl Med; 2012 Oct; 37(10):1018-21. PubMed ID: 22955081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT.
    Wu HB; Wang QS; Wang MF; Zhen X; Zhou WL; Li HS
    J Nucl Med; 2011 Mar; 52(3):341-6. PubMed ID: 21321282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
    Golan S; Sopov V; Baniel J; Groshar D
    J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of MRI, F-18 FDG, and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy.
    Tan H; Chen L; Guan Y; Lin X
    Clin Nucl Med; 2011 Nov; 36(11):978-81. PubMed ID: 21975383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
    Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting personalized medicine in a non-Hodgkin lymphoma patient with 18F-FDG and 18F-choline PET/CT.
    Ribeiro TH; S R; Castro AC; Paulino E; Mamede M
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):109-111. PubMed ID: 28355370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.
    Chotipanich C; Kunawudhi A; Promteangtrong C; Tungsuppawattanakit P; Sricharunrat T; Wongsa P
    Asian Pac J Cancer Prev; 2016; 17(7):3569-73. PubMed ID: 27510010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia.
    Zhou WL; Wu HB; Wang LJ; Tian Y; Dong Y; Wang QS
    Eur J Radiol; 2016 Jan; 85(1):205-210. PubMed ID: 26724667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.